JP2021508313A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021508313A5 JP2021508313A5 JP2020518541A JP2020518541A JP2021508313A5 JP 2021508313 A5 JP2021508313 A5 JP 2021508313A5 JP 2020518541 A JP2020518541 A JP 2020518541A JP 2020518541 A JP2020518541 A JP 2020518541A JP 2021508313 A5 JP2021508313 A5 JP 2021508313A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- microbial flora
- sequence variant
- tumor
- variant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17195520.6 | 2017-10-09 | ||
| PCT/EP2017/075683 WO2018065628A2 (en) | 2016-10-07 | 2017-10-09 | Microbiota sequence variants of tumor-related antigenic epitopes |
| EP17195520 | 2017-10-09 | ||
| EPPCT/EP2017/075683 | 2017-10-09 | ||
| EP18305442.8 | 2018-04-11 | ||
| EP18305442 | 2018-04-11 | ||
| PCT/EP2018/077515 WO2019072871A2 (en) | 2017-10-09 | 2018-10-09 | MICROBIOTIC SEQUENCE VARIANTS OF ANTIGENIC EPITOPES ASSOCIATED WITH A TUMOR |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021508313A JP2021508313A (ja) | 2021-03-04 |
| JP2021508313A5 true JP2021508313A5 (enExample) | 2021-11-18 |
| JP7232825B2 JP7232825B2 (ja) | 2023-03-03 |
Family
ID=66100441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020518541A Active JP7232825B2 (ja) | 2017-10-09 | 2018-10-09 | 腫瘍関連抗原エピトープの微生物叢（ｍｉｃｒｏｂｉｏｔａ）配列変異体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20200256877A1 (enExample) |
| EP (1) | EP3694541A2 (enExample) |
| JP (1) | JP7232825B2 (enExample) |
| KR (1) | KR102823291B1 (enExample) |
| CN (1) | CN111201032B (enExample) |
| AU (1) | AU2018348432B2 (enExample) |
| CA (1) | CA3075363A1 (enExample) |
| IL (1) | IL273648B2 (enExample) |
| WO (1) | WO2019072871A2 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11712465B2 (en) | 2016-10-07 | 2023-08-01 | Enterome S.A. | Microbiota sequence variants of tumor-related antigenic epitopes |
| IL296165B2 (en) | 2016-10-07 | 2023-10-01 | Enterome S A | Immunogenic compounds for cancer treatment |
| CN117801069A (zh) | 2016-10-07 | 2024-04-02 | 恩特罗姆公司 | 用于癌症疗法的免疫原性化合物 |
| ES2935702T3 (es) | 2018-04-11 | 2023-03-09 | Enterome S A | Péptidos antigénicos para la prevención y el tratamiento del cáncer |
| US20210106652A1 (en) * | 2018-04-11 | 2021-04-15 | Enterome S.A. | Immunogenic Compounds For Treatment Of Fibrosis, Autoimmune Diseases And Inflammation |
| MX2022004598A (es) * | 2019-10-16 | 2022-09-23 | Enterome S A | Compuestos inmunogenicos para el tratamiento del cancer suprarrenal. |
| PL4021487T3 (pl) * | 2019-11-15 | 2024-04-15 | Enterome S.A. | Peptydy antygenowe do zapobiegania i leczenia nowotworów złośliwych wywodzących się z limfocytów b |
| CN112481299A (zh) * | 2020-11-20 | 2021-03-12 | 郑州大学 | 用于调节PD-1/PD-L1通路的RNAi表达质粒 |
| WO2023244997A1 (en) * | 2022-06-13 | 2023-12-21 | The University Of North Carolina At Chapel Hill | Compositions and methods for inducing anticancer immunity |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2170959E (pt) | 2007-06-18 | 2014-01-07 | Merck Sharp & Dohme | Anticorpos para o receptor humano de morte programada pd-1 |
| KR101543624B1 (ko) * | 2007-08-20 | 2015-08-11 | 온코세라피 사이언스 가부시키가이샤 | Ｆｏｘｍ１ 펩티드 및 이를 포함하는 약학적 조성물 |
| PT2119726E (pt) | 2008-05-14 | 2015-03-30 | Immatics Biotechnologies Gmbh | Novos e poderosos peptídeos para mhc classe ii derivados de survinina e neurocano |
| MX356367B (es) | 2008-12-09 | 2018-05-25 | Genentech Inc | Anticuerpos anti-pd-l1 y su uso para mejorar la funcion de celulas t. |
| EP3279215B1 (en) | 2009-11-24 | 2020-02-12 | MedImmune Limited | Targeted binding agents against b7-h1 |
| US9314516B2 (en) * | 2010-05-04 | 2016-04-19 | Cassian Yee | Conditional superagonist CTL ligands for the promotion of tumor-specific CTL responses |
| WO2012027379A2 (en) * | 2010-08-24 | 2012-03-01 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines |
| EP2639299A1 (en) | 2012-03-16 | 2013-09-18 | Invectys | Universal cancer peptides derived from telomerase |
| US9907755B2 (en) | 2013-03-14 | 2018-03-06 | Therabiome, Llc | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
-
2018
- 2018-10-09 AU AU2018348432A patent/AU2018348432B2/en active Active
- 2018-10-09 KR KR1020207013061A patent/KR102823291B1/ko active Active
- 2018-10-09 IL IL273648A patent/IL273648B2/en unknown
- 2018-10-09 WO PCT/EP2018/077515 patent/WO2019072871A2/en not_active Ceased
- 2018-10-09 CN CN201880065726.XA patent/CN111201032B/zh active Active
- 2018-10-09 EP EP18782459.4A patent/EP3694541A2/en active Pending
- 2018-10-09 US US16/753,657 patent/US20200256877A1/en not_active Abandoned
- 2018-10-09 JP JP2020518541A patent/JP7232825B2/ja active Active
- 2018-10-09 CA CA3075363A patent/CA3075363A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL273648B1 (en) | Microbiota sequence variants of tumor-related antigenic epitopes | |
| US5698396A (en) | Method for identifying auto-immunoreactive substances from a subject | |
| Sioud et al. | Profiling the immune response in patients with breast cancer by phage‐displayed cDNA libraries | |
| JP2006515749A5 (enExample) | ||
| EP0807178B1 (fr) | Proteines de mycobacteries, microorganismes les produisant et leurs utilisations vaccinales et pour la detection de la tuberculose | |
| WO1986004093A1 (en) | Methods and compositions useful in the diagnosis and treatment of autoimmune diseases | |
| JP2020500015A5 (enExample) | ||
| JP2011523550A5 (enExample) | ||
| JP2005504513A5 (enExample) | ||
| JP2019507341A5 (enExample) | ||
| JP2024023268A5 (enExample) | ||
| US20240302377A1 (en) | Methods of identifying novel proteins and antigens in cancer cells | |
| CA2110389A1 (fr) | Proteines de mycobacterium et applications | |
| DK200601181A (da) | Fiskevaccine | |
| EP1238102B1 (en) | Microbial polynucleotides expressed during infection of a host | |
| CN107759692A (zh) | 一种抗ca125的纳米抗体 | |
| CA2542104A1 (en) | Method for the identification of epitopes related to immunogenicity in biopharmaceuticals | |
| McMillan et al. | Identification and assessment of new vaccine candidates for group A streptococcal infections | |
| CN104844691A (zh) | Sox2蛋白肽适配子及其鉴定 | |
| JP2020505056A5 (enExample) | ||
| Vera-Bravo et al. | Characterising Mycobacterium tuberculosis Rv1510c protein and determining its sequences that specifically bind to two target cell lines | |
| JPH09169795A (ja) | イヌ免疫グロブリンｅペプチド断片、それをコードするｄｎａ、そのｄｎａを含む組換えベクター、その組換えベクターを含む形質転換体及び抗イヌ免疫グロブリンｅ抗体の製造法 | |
| CN109669043B (zh) | 一种mhc i结合多肽基序的鉴定方法 | |
| JP3898009B2 (ja) | 多段階差次的クローニング技術と細胞増殖制御遺伝子 | |
| CN105254757A (zh) | 羊抗兔β防御素124多克隆抗体及其制备方法和应用 |